Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Initial Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04916626
What this trial is testing

The OPUS YOUNG Trial. Early Intervention Versus Treatment as Usual for Adolescents With First-episode Psychosis

Who this might be right for
SchizophreniaSchizotypal DisorderDelusional Disorder+5 more
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital 284
Testing effectiveness (Phase 2)UnknownNCT00964626
What this trial is testing

Paclitaxel and Cisplatin as First-Line Treatment for Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer

Who this might be right for
Ovarian Cancer
Russian Academy of Medical Sciences 60
Not applicableStudy completedNCT07808489
What this trial is testing

MB2 Canals in Pediatric Maxillary First Molars

Who this might be right for
Root Canal Therapy
Sümeyra Akkoç 77
Large-scale testing (Phase 3)WithdrawnNCT03811418
What this trial is testing

Compare Pertuzumab + Trastuzumab + Vinorelbine vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast Cancer

Who this might be right for
Advanced Breast CancerHER2-positive Breast Cancer
iOMEDICO AG
Testing effectiveness (Phase 2)UnknownNCT05544149
What this trial is testing

TRT for ES-SCLC After First Line Treatment With Immune Checkpoint Inhibitors

Who this might be right for
SCLC,Extensive Stage
Zhejiang Cancer Hospital 42
Testing effectiveness (Phase 2)Study completedNCT00405938
What this trial is testing

Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast Cancer

Who this might be right for
Breast CancerBreast Neoplasms
SCRI Development Innovations, LLC 79
Large-scale testing (Phase 3)Looking for participantsNCT05760378
What this trial is testing

Famitinib in Combination With Camrelizumab and TPC in The First-line Treatment of Immunomodulatory Locally Advanced or Metastatic TNBC.

Who this might be right for
Triple-Negative Breast Cancer
Fudan University 223
Early research (Phase 1)Looking for participantsNCT06487455
What this trial is testing

A Clinical Study of SPH7485 Tablets in the Treatment of Advanced Solid Tumors.

Who this might be right for
Advanced Solid Tumor
Shanghai Pharmaceuticals Holding Co., Ltd 170
Large-scale testing (Phase 3)Study completedNCT02818725
What this trial is testing

I-MVAC +/- Panitumumab as First-line Treatment of Advanced Urothelial Carcinoma Without H-Ras Nor K-Ras Mutations

Who this might be right for
Infiltrating Urothelial CarcinomaKRAS Gene Mutation
UNICANCER 133
Testing effectiveness (Phase 2)Enrolling By InvitationNCT05947825
What this trial is testing

Sitagliptin Combined With Gemcitabine and Albumin-bound Paclitaxel in PDAC Patients

Who this might be right for
PDAC - Pancreatic Ductal Adenocarcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT01851174
What this trial is testing

Study to Evaluate Bi-weekly Dosing of Gemcitabine Plus Nab-Paclitaxel to Treat Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Carcinoma Non-resectableStage IV Pancreatic Cancer
Western Regional Medical Center 15
Testing effectiveness (Phase 2)Study completedNCT04740307
What this trial is testing

Safety and Efficacy of Coformulated Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib (E7080/MK-7902) in Advanced Hepatocellular Carcinoma (MK-1308A-004)

Who this might be right for
Advanced Hepatocellular Carcinoma
Merck Sharp & Dohme LLC 116
Testing effectiveness (Phase 2)UnknownNCT06473909
What this trial is testing

Combination of Steroid and Humanized CD25 Monoclonal Antibody as First-line Therapy for aGVHD

Who this might be right for
Acute Graft Versus Host Disease
Institute of Hematology & Blood Diseases Hospital, China 20
Testing effectiveness (Phase 2)Ended earlyNCT00880009
What this trial is testing

Study Evaluating Bosutinib-Letrozole Combination Versus Letrozole Alone In Post Menopausal Women With Breast Cancer

Who this might be right for
Breast Cancer
Pfizer 16
Testing effectiveness (Phase 2)UnknownNCT03337087
What this trial is testing

Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer

Who this might be right for
Metastatic Biliary Tract CarcinomaMetastatic Colorectal CarcinomaMetastatic Gastroesophageal Junction Adenocarcinoma+6 more
Academic and Community Cancer Research United 18
Large-scale testing (Phase 3)UnknownNCT03709316
What this trial is testing

ZL-2306 (Niraparib) as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer

Who this might be right for
Ovarian Cancer
Zai Lab (Shanghai) Co., Ltd. 384
Testing effectiveness (Phase 2)Ended earlyNCT00903006
What this trial is testing

Trial of Fulvestrant, MK-0646, and Dasatinib for Metastatic Hormone Receptor-Positive HER2-Negative Breast Cancer

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 11
Post-approval studies (Phase 4)Study completedNCT03350815
What this trial is testing

Study Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing Spondylitis

Who this might be right for
Ankylosing Spondylitis
Novartis Pharmaceuticals 322
Testing effectiveness (Phase 2)Study completedNCT04061876
What this trial is testing

First Line Therapy for High Risk Acute GVHD

Who this might be right for
aGVHDStem Cell Transplant Complications
Chinese PLA General Hospital 198
Very early researchNot Yet RecruitingNCT06243159
What this trial is testing

JY231(Internal Clinical Drug Code) Injection for the Treatment of Refractory Autoimmune Diseases

Who this might be right for
Autoimmune Diseases
Shanxi Bethune Hospital 20
Next Page